Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...
Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
"Lung cancer survival depends heavily on early detection," said Fernandez-Bussy, dean of research and a pulmonary and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results